STOCK OPTIONS AND WARRANTS (Details Narrative) - USD ($) |
1 Months Ended | 12 Months Ended | ||
---|---|---|---|---|
May 25, 2017 |
Jun. 17, 2016 |
Dec. 31, 2017 |
Dec. 31, 2016 |
|
Options granted | 35,000 | 33,000,000 | ||
Stock Options [Member] | ||||
Intrinsic value of the vested stock options price | $ 0.1659 | |||
Officer [Member] | ||||
Options granted | 33,000,000 | |||
Exercisable price | $ 0.0201 | |||
Option term | 10 years | |||
Fair value of option | $ 628,283 | |||
Extended term description |
Company extended the term of previously granted options in aggregate of 13,500,000 initially expiring from November 2019 to July 2020 by five years to November 2024 to July 2025. |
|||
Vesting, description | Monthly over 24 months | |||
Change in fair value of option modifications | $ 53,858 | |||
Stock compensation expense | $ 319,460 | $ 183,249 | ||
Stock compensation expense unamortized | $ 130,892 | |||
Weighted average remaining life | 6 months | |||
Consultant [Member] | Stock Options [Member] | ||||
Options granted | 35,000 | |||
Option term | 5 years | |||
Fair value of option | $ 5,318 | |||
Vesting, description | Immediately | |||
Exercise price | $ 0.016 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Agreed upon price for the exchange of the underlying asset. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The increase (decrease) during the period in the carrying amount of option premium contracts for energy-related commodities. No definition available.
|
X | ||||||||||
- Definition Net number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition As of the balance sheet date, the weighted-average exercise price for outstanding stock options that are fully vested or expected to vest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Description of significant modifications (such as a change in expiration dating, vesting rights, or exercise prices) to an equity-based compensation plan, including the terms of the modifications. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|